NCT06760988View on ClinicalTrials.gov

Efficacy of CL22205 to Improve Menstrual Discomfort and Quality of Life

NANot yet recruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

February 24, 2025

Primary Completion Date

October 5, 2025

Study Completion Date

January 10, 2026

Conditions
Menstrual Discomfort
Interventions
DIETARY_SUPPLEMENT

CL22205

Experimental Dose: 200 mg, Mode: Oral, once daily after breakfast Duration: 135 days

OTHER

Placebo

Mode: Oral, once daily after breakfast Duration: 135 days

All Listed Sponsors
lead

Eetho Brands, Inc

INDUSTRY

NCT06760988 - Efficacy of CL22205 to Improve Menstrual Discomfort and Quality of Life | Biotech Hunter | Biotech Hunter